Ligand Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Revenue	-	196.25	241.54	163.56	120.28	251.45	141.1	108.97	71.91	64.54	Upgrade
Revenue Growth (YoY)	-	-18.75%	47.68%	35.98%	-52.17%	78.21%	29.48%	51.53%	11.43%	31.78%	Upgrade
Cost of Revenue	-	52.83	62.18	30.42	11.35	6.34	5.37	5.57	5.81	9.14	Upgrade
Gross Profit	-	143.42	179.37	133.14	108.94	245.12	135.74	103.4	66.11	55.4	Upgrade
Selling, General & Admin	-	70.06	46.79	60.01	41.88	37.73	28.65	27.65	25.4	22.57	Upgrade
Research & Development	-	36.08	32.11	40.5	55.91	27.86	26.89	21.22	11.01	9.75	Upgrade
Other Operating Expenses	0	34.24	-3.38	-4.87	-795.93	15.79	12.12	10.64	2.38	3.46	Upgrade
Operating Expenses	-	140.38	75.52	95.64	-698.14	81.39	67.66	59.52	38.78	35.78	Upgrade
Operating Income	-	3.04	103.85	37.5	807.08	163.73	68.08	43.89	27.33	19.63	Upgrade
Interest Expense / Income	-	1.8	19.62	27.42	35.75	48.28	13.46	12.84	11.8	4.86	Upgrade
Other Expense / Income	-	-6.63	31.24	18.38	-25.31	-57.88	-2.62	22.35	-22.18	2.33	Upgrade
Pretax Income	-	7.87	52.99	-8.29	796.64	173.33	57.23	8.69	37.71	12.43	Upgrade
Income Tax	-	41.23	-4.15	-5.31	167.34	30.01	44.68	10.33	-192.12	0.41	Upgrade
Net Income	-	-33.36	57.14	-2.99	629.3	143.32	12.56	-1.64	229.82	12.02	Upgrade
Net Income Growth	-	-	-	-	339.09%	1041.45%	-	-	1811.38%	5.29%	Upgrade
Shares Outstanding (Basic)	17	17	17	16	19	21	21	21	20	20	Upgrade
Shares Outstanding (Diluted)	-	17	17	17	20	24	23	21	21	21	Upgrade
Shares Change	3.37%	-2.19%	2.50%	-14.84%	-17.91%	2.50%	12.72%	-1.87%	-0.96%	3.32%	Upgrade
EPS (Basic)	-	-1.98	3.44	-0.18	33.13	6.77	0.60	-0.08	11.61	0.59	Upgrade
EPS (Diluted)	-	-1.98	3.31	-0.18	31.85	5.96	0.53	-0.08	10.83	0.56	Upgrade
EPS Growth	-	-	-	-	434.40%	1024.53%	-	-	1833.93%	1.82%	Upgrade
Free Cash Flow	-3.85	120.02	70.53	51.49	-31.89	183.17	93.47	41.19	37.6	19.56	Upgrade
Free Cash Flow Per Share	-0.22	7.12	4.24	3.18	-1.68	8.66	4.44	1.98	1.90	0.96	Upgrade
Gross Margin	-	73.08%	74.26%	81.40%	90.57%	97.48%	96.20%	94.89%	91.93%	85.84%	Upgrade
Operating Margin	-	1.55%	42.99%	22.93%	670.99%	65.11%	48.25%	40.27%	38.00%	30.41%	Upgrade
Profit Margin	-	-17.00%	23.66%	-1.82%	523.19%	57.00%	8.90%	-1.50%	319.58%	18.63%	Upgrade
Free Cash Flow Margin	-	61.16%	29.20%	31.48%	-26.51%	72.85%	66.24%	37.80%	52.29%	30.31%	Upgrade
Effective Tax Rate	-	523.95%	-7.83%	-	21.01%	17.31%	78.06%	118.82%	-509.47%	3.30%	Upgrade
EBITDA	-	66.56	128.4	48.7	876.12	236.32	82.41	32.82	52.14	19.95	Upgrade
EBITDA Margin	-	33.92%	53.16%	29.77%	728.38%	93.98%	58.40%	30.12%	72.50%	30.91%	Upgrade
Depreciation & Amortization	37.38	56.89	55.79	29.58	43.73	14.72	11.71	11.29	2.63	2.66	Upgrade
EBIT	-	9.67	72.61	19.12	832.38	221.61	70.69	21.53	49.51	17.29	Upgrade
EBIT Margin	-	4.93%	30.06%	11.69%	692.03%	88.13%	50.10%	19.76%	68.85%	26.80%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).